Can tamoxifen prevent breast cancer?
作者信息
Paterson A H, Geggie P H
出版信息
CMAJ. 1993 Jan 15;148(2):141-4.
Abstract
摘要
相似文献
1
Can tamoxifen prevent breast cancer?他莫昔芬能预防乳腺癌吗？
CMAJ. 1993 Jan 15;148(2):141-4.
2
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.他莫昔芬用于预防乳腺癌：国家外科辅助乳腺和肠道项目P-1研究的现状
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. doi: 10.1093/jnci/dji372.
3
Tamoxifen, raloxifene and the prevention of breast cancer.他莫昔芬、雷洛昔芬与乳腺癌预防
Minerva Endocrinol. 2002 Jun;27(2):127-39.
4
The nature of tamoxifen action in the control of female breast cancer.他莫昔芬在女性乳腺癌控制中的作用本质。
In Vivo. 2001 Jul-Aug;15(4):319-25.
5
Re: tamoxifen prevention of breast cancer: an instance of the fingerpost.关于：他莫昔芬预防乳腺癌：一个路标实例。
J Natl Cancer Inst. 2000 Apr 19;92(8):657-9.
6
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.他莫昔芬降低绝经前女性对侧乳腺癌风险：一项对照随机试验的结果。
Eur J Cancer. 2009 Sep;45(14):2496-502. doi: 10.1016/j.ejca.2009.05.022. Epub 2009 Jun 15.
7
The tamoxifen controversy.
Oncol Nurs Forum. 1996 Jun;23(5):761-6.
8
Tamoxifen for breast cancer prevention.
J Fam Pract. 1998 Nov;47(5):336-7.
9
Breast cancer prevention with tamoxifen.他莫昔芬用于乳腺癌预防
Lippincotts Prim Care Pract. 2000 Jul-Aug;4(4):434-40.
10
Chemoprevention of breast cancer with tamoxifen.
IARC Sci Publ. 1996(136):95-109.
引用本文的文献
1
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors.Z-恩杂他胺在晚期妇科、硬纤维瘤及激素受体阳性实体瘤患者中的1期研究。
Oncotarget. 2021 Feb 16;12(4):268-277. doi: 10.18632/oncotarget.27887.
本文引用的文献
1
Use of tamoxifen in advanced male breast cancer.他莫昔芬在晚期男性乳腺癌中的应用。
Cancer Treat Rep. 1980 Jun-Jul;64(6-7):801-4.
2
Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer.
Eur J Cancer Clin Oncol. 1987 May;23(5):517-20. doi: 10.1016/0277-5379(87)90313-0.
3
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.原发性乳腺癌辅助性他莫昔芬治疗：对血脂及抗凝血酶III水平的影响
Breast Cancer Res Treat. 1988 Dec;12(3):307-10. doi: 10.1007/BF01811244.
4
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.一项评估他莫昔芬预防乳腺癌的急性毒性和可行性的试点试验。
Br J Cancer. 1989 Jul;60(1):126-31. doi: 10.1038/bjc.1989.235.
5
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.一项评估他莫昔芬治疗雌激素受体阳性、淋巴结阴性乳腺癌患者疗效的随机临床试验。
N Engl J Med. 1989 Feb 23;320(8):479-84. doi: 10.1056/NEJM198902233200802.
6
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.为每年接受检查的白人女性预测患乳腺癌的个体概率。
J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86. doi: 10.1093/jnci/81.24.1879.
7
Risk of cancer in women receiving hormone replacement therapy.接受激素替代疗法的女性患癌风险。
Int J Cancer. 1989 Nov 15;44(5):833-9. doi: 10.1002/ijc.2910440515.
8
Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.早期乳腺癌辅助性他莫昔芬治疗：新发原发性癌症的发生情况
Lancet. 1989 Jan 21;1(8630):117-20. doi: 10.1016/s0140-6736(89)91141-0.
9
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.
J Natl Cancer Inst. 1990 Nov 7;82(21):1693-7. doi: 10.1093/jnci/82.21.1693.
10
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme.
Eur J Cancer. 1990;26(6):680-4. doi: 10.1016/0277-5379(90)90116-b.
Zotero 插件